Literature DB >> 6985260

Acute phase proteins in chronic inflammatory bowel disease in childhood.

C A Campbell, J A Walker-Smith, P Hindocha, M Adinolfi.   

Abstract

The serum levels of five acute phase proteins (APP) were measured in 18 children with Crohn's Disease (CD) or ulcerative colitis (UC) and in two control groups. The levels of C-reactive protein, alpha 1-acid glycoprotein, alpha 1-antitrypsin, C9, and Factor B were significantly raised in patients with CD and UC with good separation from controls, but they were not entirely reliable used as screening tests unless used in combination. The levels of APP were monitored for periods varying from 18 to 28 months in each patient and found to reflect the disease activity in both CD and UC. On seven occasions the APP levels did not match the clinically assessed disease activity, but when the serum levels were related to outcome of the disease, C-reactive protein was found to be elevated--whether or not there were symptoms of the disease--in all patients who later had a relapse, while normal values were found in those who had a long remission. These results suggest that the estimation of Creative protein is of prognostic value and that its measurement is particularly useful in children with mild symptoms in whom disease activity and prognosis are difficult to assess.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6985260     DOI: 10.1097/00005176-198201020-00007

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

1.  Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse.

Authors:  E Louis; J Belaiche; C Van Kemseke; N Schaaf; P Mahieu; J Y Mary
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

2.  Predicting relapses of Crohn's disease. Clouds in the crystal ball.

Authors:  D B Sachar
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

3.  Indications for investigation of chronic gastrointestinal symptoms.

Authors:  R M Beattie; J A Walker-Smith; S H Murch
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

Review 4.  Inflammatory bowel disease in childhood.

Authors:  I W Booth; J T Harries
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

5.  Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.

Authors:  Motoaki Kuriyama; Jun Kato; Koji Takemoto; Sakiko Hiraoka; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 6.  Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.

Authors:  Jason Orlando Dimitri Musci; Jack Stephen Cornish; Jan Däbritz
Journal:  J Gastroenterol       Date:  2016-03-14       Impact factor: 7.527

7.  Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic.

Authors:  J C Cabrera-Abreu; P Davies; Z Matek; M S Murphy
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

8.  The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release.

Authors:  G S Smith; C Rieckenberg; W E Longo; D L Kaminski; J E Mazuski; Y Deshpande; T A Miller
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

9.  Microbiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis.

Authors:  Vishal Singh; Beng San Yeoh; Benoit Chassaing; Benyue Zhang; Piu Saha; Xia Xiao; Deepika Awasthi; Rangaiah Shashidharamurthy; Madhu Dikshit; Andrew Gewirtz; Matam Vijay-Kumar
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.